BridgeMD
New treatment option for Neuropathy
Official title MultiSENSory Stimulation to TArgeT Sensory Loss and ChronIc Pain in NeurOpathic PatieNts
ClinicalTrials.gov ID: NCT05483816
What this study is testing
What is VR+TENS?
VR+TENS is an investigational medicine, being studied as a potential treatment for neuropathy.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Neuropathy is a costly and disabling health issue, which consists of a degeneration of the peripheral nerves. Even though the causes may be different, such as diabetes or amputation, the consequences for neuropathic patients are multiple and extremely debilitating.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80. Healthy volunteers may be eligible.
You may be able to join if
- for healthy:
- Inclusion:
- Age 18-80
- Visual acuity\>6 on Snellen visual acuity chart
- Exclusion:
See the full eligibility criteria
- for healthy:
- Inclusion:
- Age 18-80
- Visual acuity\>6 on Snellen visual acuity chart
- Exclusion:
- Pregnancy
- Cognitive deficits (Mini Mental State Examination\<23)
- Cyber-sickness
- Prior or current psychological diseases
- Pacemakers
- Epilepsy
- Claustrophobia
- Other MRI contraindications
- Unhealed fractures
- Unhealed wounds
- Cancerous growth in proximity to feet
- Swollen, infected or inflamed areas on feet or skin eruptions on feet such as phlebitis, thrombophlebitis or varicose veins for patients:
- Inclusion:
- Age 18-80
- Visual acuity\>6 on Snellen visual acuity chart
- Diagnosis of peripheral neuropathy
- Pain in lower limbs\>=3 cm on VAS scale
- Exclusion:
- Pregnancy
- Relevant comorbidities that would affect the outcomes of the study (by judgement of physicians)
- Ulcers
- Cognitive deficits (Mini Mental State Examination\<23)
- Cyber-sickness
- Prior or current psychological diseases
- Pacemakers
- Epilepsy
- Claustrophobia
- Other MRI contraindications
- Unhealed fractures
- Unhealed wounds
- Cancerous growth in proximity to feet
The study team makes the final eligibility decision.
Where it's taking place
- Zurich, Canton of Zurich, Switzerland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Zurich, Canton of Zurich, Switzerland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.